glp 1 patient information GLP-1 Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Dietitians boost GLP-1 therapy success

Description

Does glucagon receptor activation increase hypoglycemia risk

Tirzepatide (the active ingredient in Mounjaro and Zepbound) acts on both GLP-1 and GIP receptors simultaneously

Some dietary changes, such as avoiding certain foods, can help reduce diarrhea symptoms from Ozempic

Jebb emphasized that GLP-1 drugs "are a really valuable tool in obesity treatment but obesity is a chronic relapsing condition." "One would expect that these treatments need to be continued for life, just in the same way as blood pressure medication," Jebb said

When clinically appropriate, GLP-1 therapy can help lower cardiometabolic strain and inflammatory burden while complementing, not replacing, lifestyle fundamentals such as nutrient-dense eating, regular movement, resistance training, adequate protein intake, and restorative sleep